Impact of Hydroxy‐Methyl‐Butyrate Supplementation on Malnourished Patients Assessed Using AI‐Enhanced Ultrasound Imaging
Authors:
Open Access
- 24 February 2025
- journal article
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 16 (1) , e13700
Abstract
Background: This study aimed to evaluate the effects of an oral nutritional supplement (ONS) enriched with hydroxy‐methyl‐butyrate (HMB) in subjects with disease‐related malnutrition (DRM) and to monitor these effects with an ultrasound Imaging System, based on artificial intelligence, in a real‐world study. Methods: Fifty consecutive adult patients with DRM were enrolled. The malnutrition was diagnosed by Global Leadership Initiative on Malnutrition (GLIM) criteria. For 3 months, the patients received nutritional education, and medical nutrition therapy was started with an adapted oral diet and two servings of an oral nutritional supplementation (ONS) with a hyperproteic hypercaloric formula (HMB—enriched). All patients were studied at baseline, and 3 months after intervention, with a nutritional assessment (anthropometry, bioelectrical impedanciometry [BIA], muscle ultrasonography and biochemical parameters). Ultrasound images were automatically quantified using an AI‐based ultrasound imaging system. Results: The study included 50 patients (21 men and 29 women) with a mean age of 57.8 ± 18.1 years. Following treatment with the HMB‐enriched ONS, the prevalence of sarcopenia decreased significantly (from 24% to 18%; p = 0.01) and severe malnutrition (from 14% to 2%; p = 0.01). An improvement in BIA parameters; phase angle (0.14 ± 0.02°; p = 0.02); phase angle index (0.07 ± 0.01°/m 2 ; p = 0.01); fat free mass (1.31 ± 0.12 kg; p = 0.006); skeletal muscle mass (0.51 ± 0.11 kg; p = 0.01); and skeletal muscle mass index (0.31 ± 0.13 kg/m 2 ; p = 0.01) were reported. Functional parameters as handgrip strength (1.36 ± 0.21 kg; p = 0.009) and seconds of time up and go test (1.16 ± 0.15 s; p = 0.02) showed also an improvement. The AI‐based ultrasound system detected a significant increase in the thickness of the vastus intermedius muscle (TVI) (0.09 ± 0.01 cm; p = 0.008) and an increase of the rectus femoris (TRF) (1.06 ± 0.4 cm; p = 0.07) with the consequence of a significant increase of the (TVITRF) (0.15 ± 0.02 cm; p = 0.008). The sarcopenia index is also significant (1.03 ± 0.3 cm; p = 0.03). Muscle quality, as assessed by echogenicity analysis, improved significantly: muscle index (Mi) (0.04 ± 0.01; p = 0.04) and (fat index) FATi (−0.03 ± 0.01; p = 0.03). Conclusions: The use of an HMB‐enriched ONS in DRM patients, combined with AI‐based ultrasound imaging for follow‐up, significantly improved their nutritional status, muscle mass and muscle quality as assessed by echogenicity.Keywords
This publication has 42 references indexed in Scilit:
- Muscle protein synthesis in response to nutrition and exerciseThe Journal of Physiology, 2012
- The relationship between nutritional intake and clinical outcomes in critically ill patients: results of an international multicenter observational studyIntensive Care Medicine, 2009
- Effect of beta-hydroxy-beta-methylbutyrate (HMB) on protein metabolism in whole body and in selected tissuesFood and Chemical Toxicology, 2009
- ??-Hydroxy-??-Methylbutyrate Supplementation in Critically Ill Trauma Patients2007
- Nutritional status of adult patients admitted to internal medicine departments in public hospitals in Castilla y Leon, Spain — A multi-center studyEuropean Journal of Internal Medicine, 2006
- Prevalence of nutritional depletion in a large out-patient population of patients with COPDRespiratory Medicine, 2006
- Independent association of insulin resistance with larger amounts of intermuscular adipose tissue and a greater acute insulin response to glucose in African American than in white nondiabetic womenThe American Journal of Clinical Nutrition, 2005
- Reversal of cancer-related wasting using oral supplementation with a combination of β-hydroxy-β-methylbutyrate, arginine, and glutamineThe American Journal of Surgery, 2002
- Nutritional Treatment for Acquired Immunodeficiency Virus‐Associated Wasting Using β‐Hydroxy β‐Methylbutyrate, Glutamine, and Arginine: A Randomized, Double‐Blind, Placebo‐Controlled StudyJournal of Parenteral and Enteral Nutrition, 2000
- Assessment of fat-free mass using bioelectrical impedance measurements of the human bodyThe American Journal of Clinical Nutrition, 1985